ANDA 86577, held by Watson Labs. Trimethobenzamide Hydrochloride.
As of Nov 16, 2026, ANDA 86577 (Trimethobenzamide Hydrochloride), held by Watson Labs, was first approved by FDA on Oct 19, 1982, with 10 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 19, 1982 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Trimethobenzamide Hydrochloride100MG/ML ยท injectable;injection | Trimethobenzamide Hydrochloride | Discontinued |
| Feb 19, 1999 | Supplement 12Manufacturing | Approved | None posted |
| Feb 2, 1999 | Supplement 11Manufacturing | Approved | None posted |
| Dec 4, 1996 | Supplement 9Manufacturing | Approved | None posted |
| Aug 6, 1992 | Supplement 8Labeling | Approved | None posted |
| Sep 30, 1991 | Supplement 7Labeling | Approved | None posted |
| Feb 23, 1991 | Supplement 6Manufacturing | Approved | None posted |
| Feb 23, 1991 | Supplement 5Manufacturing | Approved | None posted |
| Feb 23, 1991 | Supplement 4Manufacturing | Approved | None posted |
| Apr 30, 1986 | Supplement 2Manufacturing | Approved | None posted |
| Apr 2, 1984 | Supplement 1Manufacturing | Approved | None posted |
| Oct 19, 1982 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters